Author
Listed:
- Harriet Corvol
(Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Trousseau
Institut National de la Santé et la Recherche Médicale (INSERM) U938
Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06)
- Scott M. Blackman
(Johns Hopkins University School of Medicine)
- Pierre-Yves Boëlle
(Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06
AP-HP, Hôpital St Antoine)
- Paul J. Gallins
(University of North Carolina at Chapel Hill)
- Rhonda G. Pace
(Marsico Lung Institute/UNC CF Research Center, School of Medicine, University of North Carolina at Chapel Hill)
- Jaclyn R. Stonebraker
(Marsico Lung Institute/UNC CF Research Center, School of Medicine, University of North Carolina at Chapel Hill)
- Frank J. Accurso
(Colorado School of Public Health, University of Colorado Denver, Anschutz Medical Center
Children’s Hospital Colorado, Anschutz Medical Center
School of Medicine, Anschutz Medical Center)
- Annick Clement
(Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Trousseau
Institut National de la Santé et la Recherche Médicale (INSERM) U938
Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06)
- Joseph M. Collaco
(Johns Hopkins University School of Medicine)
- Hong Dang
(Marsico Lung Institute/UNC CF Research Center, School of Medicine, University of North Carolina at Chapel Hill)
- Anthony T. Dang
(Marsico Lung Institute/UNC CF Research Center, School of Medicine, University of North Carolina at Chapel Hill)
- Arianna Franca
(McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine)
- Jiafen Gong
(Program in Genetics and Genome Biology, The Hospital for Sick Children)
- Loic Guillot
(Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Trousseau
Institut National de la Santé et la Recherche Médicale (INSERM) U938)
- Katherine Keenan
(Program in Physiology and Experimental Medicine, The Hospital for Sick Children)
- Weili Li
(Program in Genetics and Genome Biology, The Hospital for Sick Children)
- Fan Lin
(Program in Genetics and Genome Biology, The Hospital for Sick Children)
- Michael V. Patrone
(Marsico Lung Institute/UNC CF Research Center, School of Medicine, University of North Carolina at Chapel Hill)
- Karen S. Raraigh
(McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine)
- Lei Sun
(University of Toronto
Dalla Lana School of Public Health, University of Toronto)
- Yi-Hui Zhou
(North Carolina State University)
- Wanda K. O’Neal
(Marsico Lung Institute/UNC CF Research Center, School of Medicine, University of North Carolina at Chapel Hill)
- Marci K. Sontag
(Colorado School of Public Health, University of Colorado Denver, Anschutz Medical Center
Children’s Hospital Colorado, Anschutz Medical Center
School of Medicine, Anschutz Medical Center)
- Hara Levy
(Stanley Manne Research Institute, Northwestern University Feinberg School of Medicine, Ann and Robert Lurie Children’s Hospital of Chicago)
- Peter R. Durie
(Program in Physiology and Experimental Medicine, The Hospital for Sick Children
University of Toronto)
- Johanna M. Rommens
(Program in Genetics and Genome Biology, The Hospital for Sick Children
University of Toronto)
- Mitchell L. Drumm
(School of Medicine, Case Western Reserve University)
- Fred A. Wright
(North Carolina State University
North Carolina State University)
- Lisa J. Strug
(Program in Genetics and Genome Biology, The Hospital for Sick Children
Dalla Lana School of Public Health, University of Toronto)
- Garry R. Cutting
(McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine
Johns Hopkins University School of Medicine)
- Michael R. Knowles
(Marsico Lung Institute/UNC CF Research Center, School of Medicine, University of North Carolina at Chapel Hill)
Abstract
The identification of small molecules that target specific CFTR variants has ushered in a new era of treatment for cystic fibrosis (CF), yet optimal, individualized treatment of CF will require identification and targeting of disease modifiers. Here we use genome-wide association analysis to identify genetic modifiers of CF lung disease, the primary cause of mortality. Meta-analysis of 6,365 CF patients identifies five loci that display significant association with variation in lung disease. Regions on chr3q29 (MUC4/MUC20; P=3.3 × 10−11), chr5p15.3 (SLC9A3; P=6.8 × 10−12), chr6p21.3 (HLA Class II; P=1.2 × 10−8) and chrXq22-q23 (AGTR2/SLC6A14; P=1.8 × 10−9) contain genes of high biological relevance to CF pathophysiology. The fifth locus, on chr11p12-p13 (EHF/APIP; P=1.9 × 10−10), was previously shown to be associated with lung disease. These results provide new insights into potential targets for modulating lung disease severity in CF.
Suggested Citation
Harriet Corvol & Scott M. Blackman & Pierre-Yves Boëlle & Paul J. Gallins & Rhonda G. Pace & Jaclyn R. Stonebraker & Frank J. Accurso & Annick Clement & Joseph M. Collaco & Hong Dang & Anthony T. Dang, 2015.
"Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis,"
Nature Communications, Nature, vol. 6(1), pages 1-8, December.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9382
DOI: 10.1038/ncomms9382
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9382. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.